Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.

The DNA intercalating agents 4'-(9-acridinyl-amino) methanesulfon-m-anisidide (m-AMSA) and adriamycin were studied by using filter elution methods to measure DNA single-strand breaks (SSB's), DNA-protein cross-links (DPC's), and double-stranded breaks (DSB's) in mouse leukemia L1210 cells. Both compounds produced SSB's and DPC's at nearly 1:1 ratios. The SSB's and DPC's were shown to be localized with respect to each other; this was inferred from the finding that filter assays based on protein adsorption completely prevented the elution of the DNA single-strand segments between SSB's. In the case of m-AMSA, which produces relatively high frequencies of DNA lesions, the possibility that a protein bridges across the SSB was excluded by alkaline sedimentation studies. Both compounds also produced DSB's, but the SSB/DSB ratios differed; the SSB/DSB ratios increase in the following order: ellipticine greater than adriamycin greater than m-AMSA greater than X-ray [results of this paper combined with those of Ross, W. E., & Bradley, M. O. (1981) Biochim. Biophys. Acta (in press)]. The o-AMSA isomer is much less cytotoxic than m-AMSA and did not produce protein-associated strand breaks. The simplest model to explain the results is that a protein becomes covalently bound to either the 3' or the 5' termini of the intercalator-induced strand breaks. At moderately cytotoxic doses, m-AMSA yielded much larger frequencies of protein-associated SSB's than did adriamycin. m-AMSA-induced protein-associated SSB's saturated at approximately 60000 per cell over a concentration range in which m-AMSA uptake by the cells was proportional to the drug concentration. m-AMSA was found to enter and exit from cells very rapidly at 37 degrees C; protein-associated SSB's and DSB's also appeared and disappeared rapidly. At reduced temperature, however, the appearance and disappearance of protein-associated SSB's could be blocked while m-AMSA entry and exit still occurred. The saturation behavior and temperature dependence suggest that the formation and disappearance of protein-associated strand breaks is enzymatic. The simplest hypothesis is that the linked protein is a nuclease, such as a topoisomerase, which becomes bound to one terminus of the strand break it produces. It is proposed that topoisomerases producing SSB's and DSB's are stimulated to different degrees by different intercalators.

[1]  M. Israel,et al.  Protein-associated DNA breaks and DNA-protein cross-links caused by DNA nonbinding derivatives of adriamycin in L1210 cells. , 1981, Cancer research.

[2]  A. Rich,et al.  Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG). , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[3]  W. Evans,et al.  Phase I clinical and pharmacokinetic study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide in children with cancer. , 1980, Cancer research.

[4]  A. Zander,et al.  4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia. , 1980, Annals of internal medicine.

[5]  J. Wang,et al.  Covalent bonds between protein and DNA. Formation of phosphotyrosine linkage between certain DNA topoisomerases and DNA. , 1980, The Journal of biological chemistry.

[6]  R. Ralph On the mechanism of action of 4'-[(9-acridinyl)-amino] methanesulphon-m-anisidide. , 1980, European journal of cancer.

[7]  Chung-Cheng Liu,et al.  Type II DNA topoisomerases: Enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break , 1980, Cell.

[8]  N. Cozzarelli DNA gyrase and the supercoiling of DNA. , 1980, Science.

[9]  K. Kohn,et al.  X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution. , 1979, Nucleic acids research.

[10]  K. Kohn,et al.  Relationship between cytotoxicity and DNA strand breakage produced by adriamycin and other intercalating agents. , 1979, International Journal of Radiation Oncology, Biology, Physics.

[11]  K. Kohn,et al.  DNA-protein crosslinking by trans-platinum(II)diamminedichloride in mammalian cells, a new method of analysis. , 1979, Biochimica et biophysica acta.

[12]  K. Kohn,et al.  Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. , 1979, Biochimica et biophysica acta.

[13]  N. Bachur,et al.  NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Vistica Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell. , 1979, Biochimica et biophysica acta.

[15]  K W Kohn,et al.  DNA-protein cross-linking and DNA interstrand cross-linking by haloethylnitrosoureas in L1210 cells. , 1978, Cancer research.

[16]  W. Denny,et al.  Potenial antitumor agents. 28. Deoxyribonucleic acid polyintercalating agents. , 1978, Journal of medicinal chemistry.

[17]  K W Kohn,et al.  Protein-associated DNA breaks in cells treated with adriamycin or ellipticine. , 1978, Biochimica et biophysica acta.

[18]  T. Brown,et al.  Induction of limited DNA damage by the antitumor agent Cain's acridine. , 1978, Cancer research.

[19]  L. Deaven,et al.  Kinetic response of cultured Chinese hamster cells to treatment with 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide-HCl. , 1978, Journal of the National Cancer Institute.

[20]  T. Skovsgaard Transport and binding of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells. , 1977, Biochemical pharmacology.

[21]  S. Stevens,et al.  The production and repair of double strand breaks in cells from normal humans and from patients with ataxia telangiectasia. , 1977, Biochimica et biophysica acta.

[22]  M. Waring DNA-binding characteristics of acridinylmethanesulphonanilide drugs: comparison with antitumour properties. , 1976, European journal of cancer.

[23]  W. Wilson,et al.  Structure-activity relationships for thiolytic cleavage rates of antitumor drugs in the 4'-(9-acridinylamino)methanesulfonanilide series. , 1976, Molecular pharmacology.

[24]  K. Kohn,et al.  Fractionation of DNA from mammalian cells by alkaline elution. , 1976, Biochemistry.

[25]  C. J. Gillespie,et al.  DNA strand breaks, repair, and survival in x-irradiated mammalian cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Lennartz,et al.  Oxygen--effect on strand breaks and specific end-groups in DNA of irradiated thymocytes. , 1975, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[27]  H. Crissman,et al.  Comparative effects of three nitrosourea derivatives on mammalian cell cycle progression. , 1975, Cancer research.

[28]  G. Atwell,et al.  Potential antitumor agents. 14. Acridylmethanesulfonanilides. , 1974, Journal of medicinal chemistry.

[29]  M. M. Pater,et al.  Actinomycin D-induced breakage of human KB cell DNA , 1974, Nature.

[30]  G. Atwell,et al.  The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series. , 1974, European journal of cancer.

[31]  R. Tobey Arrest of chinese hamster cells in G2 following treatment with the anti‐tumor drug bleomycin , 1972, Journal of cellular physiology.

[32]  M. Elkind Sedimentation of DNA released from Chinese hamster cells. , 1971, Biophysical journal.

[33]  M. Waring,et al.  Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence for molecular models involving intercalation. , 1970, Journal of molecular biology.

[34]  W. Veatch,et al.  Radiation-induced breaks of DNA in cultured mammalian cells. , 1969, Biophysical journal.

[35]  M. Chu,et al.  The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y). , 1968, Biochemical pharmacology.

[36]  C. Paoletti,et al.  Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro. , 1979, Biochemical pharmacology.

[37]  T. Skovsgaard Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells. , 1978, Biochemical pharmacology.

[38]  R. Johnson,et al.  Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia. , 1978, Biochemical pharmacology.

[39]  T. Kakunaga,et al.  DNA strand breaking and rejoining in response to ultraviolet light in normal human and xeroderma pigmentosum cells. , 1976, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[40]  K W Kohn,et al.  Intercalative binding of ellipticine to DNA. , 1975, Cancer research.